GLP‑1 is no longer just a weight‑loss story – it’s a full‑scale reset for food & beverage

12 Jun 2026

GLP-1 drugs could rapidly evolve beyond current use as diabetes and weight loss medications, with new research pointing to potential benefits in cancer, ageing, addiction, osteoarthritis and heart health. As evidence grows and new formats like oral therapies emerge, usage is expected to expand to other populations and health needs. This shift will reshape how and why consumers use GLP-1s, fundamentally shifting consumption behaviours. For food and beverage companies, understanding how their use might evolve will be critical to staying relevant, from reformulating products to meeting new nutritional needs. Here’s a snapshot of the latest research and what it could mean for the future of food, beverage and consumer demand.

Read full article at Beverage Daily